Exosomes in melanoma: Future potential for clinical theranostics
- 31 March 2025
- journal article
- review article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 269, 155950
Abstract
No abstract availableKeywords
This publication has 110 references indexed in Scilit:
- Assessing the quality of care for skin malignant melanoma on a global, regional, and national scale: a systematic analysis of the global burden of disease study from 1990 to 2019Archives of Dermatological Research, 2023
- Clinical Translation of Extracellular VesiclesAdvanced Healthcare Materials, 2023
- Plant‐derived extracellular vesicles: Recent advancements and current challenges on their use for biomedical applicationsJournal of Extracellular Vesicles, 2022
- Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040JAMA Dermatology, 2022
- Exosome-mediated delivery of transforming growth factor-β receptor 1 kinase inhibitors and toll-like receptor 7/8 agonists for combination therapy of tumorsActa Biomaterialia, 2022
- Characterization of genetics in patients with mucosal melanoma treated with immune checkpoint blockadeCancer Medicine, 2021
- Profiling of Exosomal Biomarkers for Accurate Cancer Identification: Combining DNA‐PAINT with Machine‐ Learning‐Based ClassificationSmall, 2019
- Blockage of transferred exosome‐shuttled miR‐494 inhibits melanoma growth and metastasisJournal of Cellular Physiology, 2019
- Exosomes in Cancer: Another Mechanism of Tumor-Induced Immune Suppression2017
- Tumor-Derived Exosomes and Their Role in Cancer Progression2016